61
Views
4
CrossRef citations to date
0
Altmetric
Theme: Demyelinating diseases - Key Paper Evaluation

Is there a future for donepezil therapy in the treatment of multiple sclerosis-related cognitive impairment?

&
Pages 1243-1246 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Andrew Davis, Ronald N. Williams, Ajay S. Gupta, W. Holmes Finch & Christopher Randolph. (2015) Evaluating Neurocognitive Deficits in Patients With Multiple Sclerosis Via a Brief Neuropsychological Approach. Applied Neuropsychology: Adult 22:5, pages 381-387.
Read now

Articles from other publishers (3)

Karen D. Lariosa-Willingham, Elen S. Rosler, Jay S. Tung, Jason C. Dugas, Tassie L. Collins & Dmitri Leonoudakis. (2016) A high throughput drug screening assay to identify compounds that promote oligodendrocyte differentiation using acutely dissociated and purified oligodendrocyte precursor cells. BMC Research Notes 9:1.
Crossref
Elen S. Rosler, Karen D. Lariosa-Willingham, Jay S. Tung, Jason C. Dugas, Tassie L. Collins & Dmitri Leonoudakis. (2016) Development of a high throughput drug screening assay to identify compounds that protect oligodendrocyte viability and differentiation under inflammatory conditions. BMC Research Notes 9:1.
Crossref
Nastaran Majdinasab, Amir Siahpush, Seyedeh Khatoon Mousavinejad, Alireza Malayeri, Seyed Aidin Sajedi & Parisa Bizhanzadeh. (2016) Effect of Boswellia serrata on cognitive impairment in multiple sclerosis patients. Journal of Herbal Medicine 6:3, pages 119-127.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.